Sequential Compression System Market Summary
The global sequential compression system market was valued at USD 1.27 billion in 2025 and is expected to grow significantly, reaching USD 2.47 billion by 2033. This growth represents a strong compound annual growth rate (CAGR) of 8.34% during the forecast period from 2026 to 2033. The expansion of this market is largely driven by the increasing prevalence of venous thromboembolism (VTE), deep vein thrombosis (DVT), and other circulatory disorders. These conditions are particularly common among aging populations, individuals with obesity, and patients recovering from surgical procedures, all of which contribute to a higher demand for effective preventive solutions such as sequential compression systems.
Growing awareness regarding the clinical advantages of non-invasive mechanical prophylaxis is playing a crucial role in market development. Healthcare professionals and institutions are increasingly adopting these systems due to strong recommendations for DVT prevention in perioperative and critical care guidelines. Moreover, the rising shift toward outpatient surgeries and home-based healthcare settings is significantly boosting the demand for portable and easy-to-use sequential compression devices. Patients and caregivers are seeking convenient solutions that ensure safety while allowing mobility and comfort. Technological advancements have further enhanced the appeal of these systems, with innovations such as lightweight designs, automated pressure regulation, and wearable configurations improving both patient compliance and treatment effectiveness. These ongoing developments continue to support the long-term growth of the market.
Key Market Trends & Insights
- North America held the leading position in the sequential compression system market, accounting for the largest revenue share of 38.0% in 2025, supported by advanced healthcare infrastructure and high awareness levels.
- Within North America, the United States represented the largest contributor to market revenue in 2025, driven by widespread adoption of advanced medical technologies and strong clinical guidelines.
- Based on product type, the consumables and accessories segment accounted for the largest revenue share in 2025, owing to their recurring usage and essential role in the effective functioning of compression systems.
- In terms of technology, the simultaneous sequential compression (SSC) segment dominated the market in 2025, as it offers efficient and consistent pressure delivery, enhancing therapeutic outcomes.
- By application, the deep vein thrombosis (DVT) prevention segment held the largest revenue share in 2025, reflecting the growing emphasis on preventive care and the high incidence of DVT among at-risk patient populations.
Order a free sample PDF of the Sequential Compression System Market Intelligence Study, published by Grand View Research.
Market Size & Forecast
- 2025 Market Size: USD 1.27 Billion
- 2033 Projected Market Size: USD 2.47 Billion
- CAGR (2026-2033): 8.34%
- North America: Largest market in 2025
Key Companies & Market Share Insights
The sequential compression system market is largely led by a few established global manufacturers that hold a sizable share due to strong brand presence, wide product portfolios, and direct-to-consumer channels.
Key Players
- Cardinal Health
- Arjo
- Tactile Medical
- Bio Compression Systems
- Enovis
- Mego Afek
- Zimmer Biomet
- AIROS Medical
- Hyperice
- Therabody
- BREG, Inc.
Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.
Conclusion
The sequential compression system market is set for robust growth in the coming years, driven by the rising burden of circulatory disorders and increasing awareness of preventive healthcare measures. Advancements in device technology and the shift toward patient-centric care models are further strengthening market expansion. The growing adoption of portable and home-use devices highlights changing healthcare delivery trends. North America continues to lead due to strong infrastructure and clinical adoption, while other regions are gradually catching up. Overall, continuous innovation, improved accessibility, and a focus on better patient outcomes will remain key factors supporting sustained market growth globally.